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Neha Chaudhary, MD; Ruben Vaidya, MD; Ivana Culic, MD; Rachana Singh, MD, MS; Diana Yanni, MD; Silvia Patrizi, MD; Mark L. Hudak, MD;
Margaret G. Parker, MD, MPH; Mandy B. Belfort, MD, MPH
Abstract
IMPORTANCE The incidence of mother-to-newborn SARS-CoV-2 transmission appears low and may
be associated with biological and social factors. However, data are limited on the factors associated
with neonatal clinical or viral testing outcomes.
OBJECTIVE To ascertain the percentage of neonates who were born to mothers with positive SARS-
CoV-2 test results during the birth hospitalization, the clinical and sociodemographic factors
associated with neonatal test result positivity, and the clinical and virological outcomes for newborns
during hospitalization and 30 days after discharge.
DESIGN, SETTING, AND PARTICIPANTS This multicenter cohort study included 11 academic or
community hospitals in Massachusetts and mother-neonate dyads whose delivery and discharge
occurred between March 1, 2020, and July 31, 2020. Eligible dyads were identified at each
participating hospital through local COVID-19 surveillance and infection control systems. Neonates
were born to mothers with positive SARS-CoV-2 test results within 14 days before to 72 hours after
delivery, and neonates were followed up for 30 days after birth hospital discharge.
EXPOSURES Hypothesized maternal risk factors in neonatal test result positivity included maternal
COVID-19 symptoms, vaginal delivery, rooming-in practice, Black race or Hispanic ethnicity, and zip
code–derived social vulnerability index. Delivery indicated by worsening maternal COVID-19
symptoms was hypothesized to increase the risk of adverse neonatal health outcomes.
MAIN OUTCOMES AND MEASURES Primary outcomes for neonates were (1) positive SARS-CoV-2
test results, (2) indicators of adverse health, and (3) clinical signs and viral testing. Test result
positivity was defined as at least 1 positive result on a specimen obtained by nasopharyngeal swab
using a polymerase chain reaction–based method. Clinical and testing data were obtained from
electronic medical records of nonroutine health care visits within 30 days after hospital discharge.
RESULTS The cohort included 255 neonates (mean [SD] gestational age at birth, 37.9 [2.6] weeks;
62 [24.3%] with low birth weight or preterm delivery) with 250 mothers (mean [SD] age, 30.4 [6.3]
years; 121 [48.4%] were of Hispanic ethnicity). Of the 255 neonates who were born to mothers with
SARS-CoV-2 infection, 225 (88.2%) were tested for SARS-CoV-2 and 5 (2.2%) had positive results
during the birth hospitalization. High maternal social vulnerability was associated with higher
likelihood of neonatal test result positivity (adjusted odds ratio, 4.95; 95% CI, 1.53-16.01; P = .008),
adjusted for maternal COVID-19 symptoms, delivery mode, and rooming-in practice. Adverse
outcomes during hospitalization were associated with preterm delivery indicated by worsening
maternal COVID-19 symptoms. Of the 151 newborns with follow-up data, 28 had nonroutine clinical
visits, 7 underwent SARS-CoV-2 testing, and 1 had a positive result.
(continued)
Key Points
Question What are the test result
positivity rate and health outcomes of
maternal SARS-CoV-2 infection among
perinatally exposed newborns?
Findings In this cohort study of 255
neonates born to women with positive
SARS-CoV-2 test results within 2 weeks
before and 72 hours after delivery,
88.2% of newborns were tested for the
virus during the birth hospitalization
and 2.2% had positive results. A main
risk factor for neonatal test result
positivity was maternal social
vulnerability, and the burden of SARS-
CoV-2 exposure on newborn health was
associated with preterm delivery, which
was prompted by worsening maternal
COVID-19 illness.
Meaning Results of this study indicate
that neonates who were perinatally
exposed to SARS-CoV-2 can sustain
adverse health outcomes both directly
(as evidenced by higher test result
positivity rates when born to socially
vulnerable mothers) and indirectly
(given the sequelae of preterm birth).
+ Supplemental content
Author affiliations and article information are
listed at the end of this article.
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Abstract (continued)
CONCLUSIONS AND RELEVANCE The findings emphasize the importance of both biological and
social factors in perinatal SARS-CoV-2 infection outcomes. Newborns exposed to SARS-CoV-2 were at
risk for both direct and indirect adverse health outcomes, supporting efforts of ongoing surveillance
of the virus and long-term follow-up.
JAMA Network Open. 2021;4(4):e217523. doi:10.1001/jamanetworkopen.2021.7523
Introduction
Biologically plausible routes of perinatal SARS-CoV-2 transmission include transplacental, contact
with infected secretions during delivery and with respiratory droplets after delivery, and breast milk.
Low rates of virus positivity in relevant biological specimens1-3 suggest that perinatal transmission is
uncommon, but accumulating evidence indicates that some neonates who are born to mothers with
SARS-CoV-2 do obtain positive test results for the virus.1 Systematic reviews of case series of mothers
with SARS-CoV-2 reported a neonatal test result positivity rate of 3.1% to 9.1%,4-6 but such reviews
included mainly small studies from single centers, limiting the generalizability of the findings and
raising the possibility of selection and/or publication bias.7 Larger multihospital cohorts from New
York City included up to 149 mothers with SARS-CoV-2 and reported a test result positivity rate of less
than 1% in neonates.8,9 Overall, considerable uncertainty remains about the true incidence of
neonatal test result positivity, which can serve as a proxy for perinatal transmission.
Given the low incidence of neonatal test result positivity for SARS-CoV-2, identifying the risk
factors associated with its occurrence is challenging. Mothers who present with COVID-19 symptoms
may have higher SARS-CoV-2 viral loads and be more likely to transmit the virus than mothers who
are identified by routine screening.10 Clinical practices that were initially recommended to reduce
perinatal transmission included elective cesarean delivery, mother-newborn separation, and
temporary suspension of breastfeeding.11 Subsequently, based on accumulating evidence, the
American Academy of Pediatrics promoted rooming-in and breastfeeding with precautions.12 In
addition to clinical factors, social adversity may play a role given that the COVID-19 pandemic has
disproportionately affected racial/ethnic minority populations. The specific pathways by which social
disadvantage might affect mother-to-child transmission of SARS-CoV-2 include differential access to
care and clinician bias.13 Discrimination also may be a factor in chronic stress, which diminishes
antiviral immune responses.14,15 To our knowledge, no epidemiologic study to date has examined the
risk factors for neonatal test result positivity.
Several studies have reported short-term health outcomes for neonates who were born to
mothers with SARS-CoV-2, including the need for neonatal intensive care unit admission and
respiratory support,16,17 but little is known about the specific factors associated with neonatal clinical
or viral testing outcomes beyond the birth hospital discharge. One New York City hospital routinely
followed perinatally exposed newborns and found that none had clinically significant signs of SARS-
CoV-2 infection and 6 had negative test results.18 Also in New York City, a 3-hospital cohort study of
120 neonates who were exposed to SARS-CoV-2 reported 0 positive result from nasopharyngeal
swabs taken at 5 to 7 days and 14 days of life during follow-up, and no clinical concerns in telehealth
evaluations at 1 month of age were reported.9 Although these previous studies did not suggest that
substantial clinical illness in newborns commonly followed perinatal exposure to SARS-CoV-2, more
data are needed.
Large, geographically defined cohort studies that track newborns after hospital discharge are
needed to accurately define the incidence of neonatal test result positivity for SARS-CoV-2 and to
identify the factors associated with increased positive test results. Within a statewide cohort, we
conducted a cohort study with the following objectives: (1) to ascertain the percentage of neonates
who were born to mothers with positive SARS-CoV-2 test results during the birth hospitalization, (2)
to identify clinical and sociodemographic factors associated with neonatal test result positivity, and
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(3) to describe the clinical and virological outcomes for perinatally exposed newborns during the
birth hospitalization and 30 days after discharge. We hypothesized that maternal COVID-19
symptoms, vaginal delivery mode, rooming-in practice, racial/ethnic minority status, and social
vulnerability would be associated with increased likelihood of neonatal test result positivity for SARS-
CoV-2. We also hypothesized that delivery indicated by worsening maternal COVID-19 symptoms
would increase the risk for adverse neonatal health outcomes.
Methods
This cohort study was approved by the institutional review board of each of the 11 participating
hospitals, which deemed this study as having minimal risk and could not be performed without the
waiver of informed consent. We followed the Strengthening the Reporting of Observational Studies
in Epidemiology (STROBE) reporting guideline.
Study Design, Sites, Population, and Data Sources
This study included 11 academic or community hospitals in Massachusetts (Baystate Medical Center,
Baystate; Beth Israel Deaconess Medical Center, Boston; Beverly Hospital, Beverly; Brigham and
Women's Hospital, Boston; Boston Medical Center, Boston; Cambridge Health Alliance, Cambridge;
Massachusetts General Hospital, Boston; Newton-Wellesley Hospital, Newton; Tufts Children's
Hospital, Boston; UMass Memorial Health Center, Worcester; and Winchester Hospital, Winchester).
These hospitals are geographically dispersed within the state; serve a racially/ethnically, culturally,
and socially diverse population; and capture data on approximately 37 000 births per year or 52% of
annual births within the state (eFigure in the Supplement).19 We identified all neonates who were
born to mothers with a positive result on the nasopharyngeal polymerase chain reaction test for
SARS-CoV-2 from 14 days before to 72 hours after delivery, an inclusion criterion of the National
Registry for Surveillance and Epidemiology of Perinatal COVID-19 Infection of the American Academy
of Pediatrics.20 For this analysis, we selected mother-newborn dyads whose delivery and discharge
occurred between March 1, 2020, and July 31, 2020.
Eligible dyads were identified at each hospital through local COVID-19 surveillance and infection
control systems. All data were collected manually by hospital-based teams from electronic medical
records (EMRs) using a standardized case report form, which was developed by the National Registry
for Surveillance and Epidemiology of Perinatal COVID-19 Infection.20 We used REDCap as the
electronic data capture system.21,22
Exposures and Covariates
Hospital data included maternal demographic characteristics; maternal SARS-CoV-2 infection,
testing, and treatment; pregnancy and delivery characteristics; and hospital outcomes for mother
and newborn. For this study, the participating hospitals also collected data on maternal occupation,
zip code of primary residence, and neonatal encounters up to 30 days after the birth hospitalization,
including the type of and reason for the encounter as well as any SARS-CoV-2 testing. During the
study period, pregnant women were tested for SARS-CoV-2 according to the guidelines of the
individual hospitals, most of which had implemented universal screening by April 27, 2020.23
We used the primary residence zip code to calculate the Social Vulnerability Index (SVI),24 a
measure developed by the Centers for Disease Control and Prevention that uses 15 US Census
variables to identify socially vulnerable populations. The SVI has 4 themes based on the American
Community Survey census estimates for 2015 to 2018: (1) socioeconomic status, including below
poverty, unemployment, median income, and no high school diploma; (2) household composition
and disability, including age 65 years or older, age 17 years or younger, disability status, and single-
parent household; (3) racial/ethnic minority and language status, including speaks English less than
well; and (4) housing and transportation type, including multiunit structure, mobile home, crowding,
group quarter, and no vehicle. For each census tract, percentile ranks are generated for the 15
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individual variables, the 4 themes, and the overall tract ranking. The SVI scores range from 0,
representing the lowest, to 1, representing the highest level of vulnerability. We used overall tract
ranking as the indicator for geography-based social vulnerability, with 90th percentile or higher being
the most vulnerable.
Outcomes
Primary neonatal outcomes were (1) positive SARS-CoV-2 test result during the birth hospitalization;
(2) indicators of adverse health during the birth hospitalization, including preterm birth (<37 weeks)
or low birth weight (<2500 g), very preterm birth (<32 weeks) or very low birth weight (<1500 g),
delivery room resuscitation (positive pressure ventilation, intubation, and/or chest compressions),
continuous positive airway pressure (CPAP) or mechanical ventilation, therapeutic hypothermia, and
length of stay; and (3) clinical signs and viral testing, which were identified through EMR
documentation of nonroutine health care visits through 30 days after hospital discharge. Test result
positivity for SARS-CoV-2 was defined as at least 1 positive result on a specimen obtained by
nasopharyngeal swab using a polymerase chain reaction–based method.
Statistical Analysis
We performed a comparison between neonates with any positive SARS-CoV-2 test results and those
with negative test results on the basis of sociodemographic characteristics, pregnancy and delivery
factors, and newborn care practices while accounting for hospital clustering using Cochran-Mantel-
Haenszel χ2 tests for categorical variables. A 2-tailed P < .05 was considered statistically significant.
For multivariable analyses, we selected covariates for parsimonious models according to a priori
hypotheses and associations observed in unadjusted analyses, and we used mixed-effects logistic
regression models to account for hospital clustering. Because of the small number of neonates with
positive SARS-CoV-2 test results, we used a robust sandwich estimator to estimate odds ratios (ORs)
with 95% CIs.
We hypothesized that the following variables would increase the risk of the neonatal test result
positivity: maternal symptomatic SARS-CoV-2 infection, vaginal delivery mode, any rooming-in
practice, Black race or Hispanic ethnicity, language status (non-English vs English), and SVI of 90th
percentile or higher. Furthermore, we hypothesized that delivery prompted by worsening maternal
SARS-CoV-2 infection–related clinical status would be associated with indicators of adverse neonatal
health outcomes.
If outcome data were missing, the participant was removed from the analysis. We used SAS,
version 9.4 (SAS Institute Inc) for all analyses.
Results
Birth Hospital Data
From the 11 participating hospitals, we identified 255 neonates who were born to 250 mothers with
positive SARS-CoV-2 test results. Maternal demographic characteristics are outlined in Table 1. The
mean (SD) maternal age was 30.4 (6.3) years, and 121 (48.4%) were Hispanic mothers of any race, 50
(20.0%) were non-Hispanic White mothers, and 46 (18.4%) were non-Hispanic Black mothers. For
the zip code–derived SVI, 68 mothers (27.2%) had an overall score of 90th percentile or higher. A
total of 170 mothers (68.0%) were asymptomatic when tested for SARS-CoV-2, which was a
consequence of the implementation of universal surveillance testing. Of the 79 women with
symptomatic COVID-19, 23 (29.1%) required hospitalization and/or received medication for COVID-19
treatment before delivery. Worsening COVID-19 illness prompted delivery in 23 mothers (9.2%), of
which 20 (87.0%) were cesarean deliveries. In 52 of 113 cesarean deliveries (46.0%), rupture of
membranes occurred at birth, which limited the exposure of the fetus to maternal genital tract flora
before delivery.
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Total No. of women 250
Age, mean (SD), y 30.4 (6.3)
Maternal race/ethnicity













Health care 29 (11.6)
Service professions 43 (17.2)
Other or unknowna 71 (28.4)
SVI, based on zip code
Percentile ranking (higher = more vulnerable), mean (SD)
Socioeconomic status theme 65.7 (23.4)
Household composition and disability theme 53.5 (29.6)
Racial/ethnic minority and language status theme 71.4 (25.7)
Housing and transportation type theme 71.4 (22.2)
Overall percentile ranking 70.1 (24.0)
90th Percentile group: most vulnerable
Overall 68 (27.2)




Days from first positive SARS-CoV-2 test result to delivery,
mean (SD)
4.0 (5.2)
Severity of maternal COVID-19 illness
Asymptomatic 170 (68.0)
Symptomatic 79 (31.6)
Hospitalized and/or received medication for COVID-19
before delivery
23 (29.1)b
Sick at home before admission only 56 (70.9)b
Unknown (outborn) 1 (0.4)b
Pregnancy and delivery characteristics







ROM at delivery 52 (46.0)b
(continued)
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Neonatal characteristics are outlined in Table 2. The mean (SD) gestational age at birth was 37.9
(2.6) weeks; 13 neonates (5.1%) were small for gestational age (<10th percentile),25 and 62 (24.3%)
were delivered either at low birth weight or preterm. Among the newborns, 49 (19.2%) required
resuscitation at birth, 88 (34.5%) were separated from their mothers, and 152 (59.6%) were directly
breastfed. Four neonates (1.6%) had neonatal encephalopathy and underwent therapeutic
hypothermia; all 4 had negative SARS-CoV-2 test results, and their mothers had only mild COVID-19
symptoms. We observed 1 newborn death that was secondary to severe hypoxic ischemic
encephalopathy; this newborn’s mother had mild SARS-CoV-2 infection–related symptoms, and the
newborn had 2 negative SARS-CoV-2 test results at 24 and 48 hours.
During their hospital stay, 225 neonates (88.2%) were tested for SARS-CoV-2 and 5 (2.2%) had
positive results (Table 2). Thus, the test result positivity rate was 2.2% (95% CI, 1.0-5.1) among
newborns tested before hospital discharge. A total of 124 newborns (55.1% of those tested)
underwent only 1 test during their birth hospitalization. Including all 6 neonates with positive SARS-
CoV-2 test results within the first week of life (eTable 1 in the Supplement), the test result positivity
rate was 2.7% among those who were tested. Two neonates who presented with respiratory distress
were delivered preterm: 1 newborn had nasal congestion, and 3 newborns were asymptomatic. We
found no substantial differences in maternal or neonatal characteristics between neonates who were
tested and those who were not during their hospitalization (eTable 2 in the Supplement).
Risk Factors Associated With Neonatal Test Result Positivity
Characteristics of neonates with negative and those with positive SARS-CoV-2 test results are shown
in eTable 3 in the Supplement. In unadjusted analyses, neonates with positive test results were more
likely to be born to mothers with symptomatic COVID-19 (OR, 1.84; 95% CI, 0.51-6.58; P = .35), less
likely to be delivered vaginally (OR, 0.39; 95% CI, 0.12-1.22; P = .11), and less likely to room-in (OR,
0.26; 95% CI, 0.02-3.07; P = .29), but none of these results was statistically significant (Table 3).
Individual-level racial/ethnic minority status or non–English-speaking status was not associated with
a higher risk of the newborn having a positive test result (OR, 0.81; 95% CI, 0.09-7.66; P = .85).
Adjusting for maternal symptoms, delivery mode, and rooming-in practice, mothers with high SVI
(90th percentile) were more likely to have neonates with positive SARS-CoV-2 test results
(adjusted OR, 4.95; 95% CI, 1.53-16.01; P = .008) (Table 3).
Adverse Neonatal Health Outcomes and Maternal Delivery Indication
Table 4 shows that all adverse neonatal health outcomes (preterm or low birth weight, very preterm
or very low birth weight, delivery room resuscitation, CPAP or mechanical ventilation, and length of
stay) were increased among neonates who were born to mothers whose worsening COVID-19 illness
Table 1. Maternal Demographic and Pregnancy
and Delivery Characteristics (continued)
Variable No. (%)







Abbreviations: ROM, rupture of membranes; SVI, Social Vulnerability Index.
a Other occupation categories include finance and marketing, manufacturing
and engineering, and student.
b The denominator for this variable is a fraction of the total cohort.
c Other includes American Indian or Alaska Native, Native Hawaiian or Pacific
Islander.
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Table 2. Neonatal Characteristics and Birth Hospitalization Data
Variable No. (%)
Neonatal characteristics
Total No. of neonates 255
Gestational age, mean (SD), wk 37.9 (2.6)
Birth weight, mean (SD), g 3116.3
(655.6)
Apgar at 5 min, mean (SD) 8.62 (1.15)
Female sex 131 (51.4)
SGA (<10th percentile)a 13 (5.1)
Very preterm birth (<32 wk) or VLBW (<1500 g) 6 (2.4)
Preterm birth (<37 wk) or LBW (<2500 g) 62 (24.3)
Resuscitation at birth
Drying and stimulation only 202 (79.2)
Oxygen 4 (1.6)















Respiratory distress 33 (12.9)
Fever (>37.8 °C) 1 (0.4)





CPAP or mechanical ventilation 40 (15.7)
Diagnoses
None 187 (73.3)
Routine newbornb 16 (6.3)
Congenital anomaliesc 12 (4.7)
Infection concerns 12 (4.7)
Surfactant deficiency 10 (3.9)






Antibiotics or antivirals (acyclovir) 32 (12.6)
IV fluids 39 (15.3)
Surfactant 11 (4.3)
iNO, pressors or hydrocortisone 4 (1.6)
Therapeutic hypothermia 4 (1.6)
(continued)
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led to a delivery indication. Of 62 preterm births, 17 (27.4%) were indicated by maternal worsening
symptoms, but we did not otherwise collect data on the indication for preterm delivery. Among the
neonates who were delivered for worsening maternal illness, 17 (73.9%) were delivered preterm.
Newborn Follow-up Data 30 Days After Hospital Discharge
Of the 255 neonates who were exposed to SARS-CoV-2, 151 (59.2%) had at least 1 postdischarge
medical encounter documented in the EMR (Table 5). The demographic characteristics were similar
for neonates with and those without postdischarge EMR information except the month of birth
differed significantly between the 2 groups (eTable 4 in the Supplement). Most encounters were for
routine care, whereas 28 were nonroutine visits, including 18 visits to urgent care or an emergency
department. None of the neonates who received routine care only underwent testing for SARS-
CoV-2, whereas 7 neonates with nonroutine encounters were tested; 1 had a positive SARS-CoV-2
test result on day 5 of life during an emergency department visit for nasal congestion (eTable 1 in the
Supplement). Four neonates were rehospitalized in the first 30 days after discharge, and none was
for conditions directly associated with SARS-CoV-2 infection (eTable 5 in the Supplement).
Table 2. Neonatal Characteristics and Birth Hospitalization Data
(continued)
Variable No. (%)
Any SARS-CoV-2 test during the birth hospitalization
No 30 (11.8)
Yes 225 (88.2)
Tested once 124 (55.1)f
Tested more than once 101 (44.8)f
Positive result 5 (2.2)f
SARS-CoV-2 positive result overall 5 (2.0)
Hospital care practices
Any rooming-in with mother 167 (65.5)
Direct nursing by mother 138 (82.6)f
No rooming-in 88 (34.5)
Direct nursing by mother 14 (15.9)f
Any NICU stay 72 (81.8)f
Any maternal milk feeding
Direct nursing 152 (59.6)
Expressed milk fed by mother or another caregiver 78 (30.6)
Abbreviations: CPAP, continuous positive airway pressure; iNO, inhaled nitric
oxide; IV, intravenous; LBW, low birth weight; LOS, length of stay; NICU,
neonatal intensive care unit; SGA, small for gestational age; VLBW, very low
birth weight.
a Calculated per Olsen growth charts.25
b Routine newborn diagnoses include prematurity, apnea of prematurity,
feeding immaturity, immature thermoregulation, ankyloglossia,
hyperbilirubinemia, ABO incompatibility, failed car seat test, hemangioma,
cephalohematoma, low resting heart rate, and slow feeding.
c Congenital anomalies include ear pit, tracheoesophageal fistula,
hydronephrosis or pyelectasis, and Smith-Lemli-Opitz syndrome.
d Respiratory issues other than surfactant deficiency include delayed transition,
pulmonary hypertension, hypoxemia, and desaturation.
e Other includes hypotension, hypothermia, intraventricular hemorrhage, and
microcephaly.
f The denominator for this variable is a fraction of the total cohort.
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Discussion
To our knowledge, this study presented data for the largest US cohort of neonates who were born to
mothers with positive SARS-CoV-2 test results. Among the 255 mother-newborn dyads from 11
hospitals in Massachusetts, we found a 2.2% test result positivity rate in neonates who underwent
SARS-CoV-2 testing during birth hospitalization. In addition, we identified maternal social
Table 3. Factors Associated With Positive SARS-CoV-2 Test Results Among 226 Neonatesa
Variable
Unadjusted Adjusted
OR (95% CI) P value OR (95% CI) P value
Maternal SVI ≥90th percentile vs other 5.49 (2.11-14.29) .001 4.95 (1.53-16.01) .008
Maternal symptomatic vs asymptomatic
COVID-19
1.84 (0.51-6.58) .35 0.71 (0.49-1.02) .07
Vaginal vs cesarean delivery 0.39 (0.12-1.22) .11 0.47 (0.16-1.40) .18
Any vs no rooming-in 0.26 (0.02-3.07) .29 0.29 (0.04-2.29) .24
Racial/ethnic minority or non–English
speaker vs other
0.81 (0.09-7.66) .85 NA NA
Abbreviations: NA, not applicable; OR, odds ratio; SVI,
Social Vulnerability Index.
a Mixed-effects regression models accounted for
hospital clustering using a robust sandwich
estimator. Positive test occurred in the first 5 days
after delivery. This analysis includes 6 newborns with
a positive SARS-CoV-2 test result within the first
week of life (5 positive results during the birth
hospitalization, and 1 positive result after discharge
on day 5 of life).






COVID-19 illness (n = 23) Other (n = 232)
Delivery room resuscitationb 14 (60.9) 35 (15.1) <.001
Preterm birth (<37 wk) or LBW (<2500 g) 17 (73.9) 45 (19.4) <.001
Very preterm birth (<32 wk) or VLBW (<1500 g) 7 (30.4) 10 (4.3) <.001
Respiratory supportc 15 (65.2) 25 (10.8) <.001
Therapeutic hypothermia 1 (4.4) 3 (1.3) .17
Newborn LOS, d
Mean (SD) 17.6 (24.0) 5.1 (8.5) <.001
Median (IQR) 9.5 (4-18) 3 (2-4) <.001
Abbreviations: IQR, interquartile range; LBW, low birth
weight; LOS, length of stay; VLBW, very low
birth weight.
a P values account for hospital-level clustering.
b Delivery room resuscitation includes positive-
pressure ventilation, intubation, and/or chest
compressions.
c Respiratory support is continuous positive airway
pressure or mechanical ventilation.
Table 5. Follow-up Data of Neonates in the First 30 Days After Hospital Discharge
30-d Postdischarge data No. (%)
Total No. of neonates with ≥1 encounter 151 (59.2)
Neonates with SARS-CoV-2 testing 7 (4.6)
Positive result among neonates with known follow-up encounters 1 (0.7)
Positive result among neonates tested 1 (14.3)
Neonates with asymptomatic visits only 123 (81.5)
SARS-CoV-2 test sent 0
Neonates with any symptomatic visits 28 (18.5)
SARS-CoV-2 test sent 7 (25.0)
Location of visit
Pediatric clinic 23 (82.1)





Gastrointestinal (emesis, constipation) 4 (14.3)
Respiratory 8 (28.6)
Fever 1 (3.6)
Lethargy, poor feeding 1 (3.6)
Other or newborn-relateda 9 (32.1)
Abbreviation: ED, emergency department.
a Fall, fussiness, rash, and spit-up.
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vulnerability, as defined by zip code, as a risk factor for neonatal test result positivity, whereas
maternal COVID-19 symptoms, delivery mode, and rooming-in practice were not significant factors.
Adverse health outcomes among neonates who were born to mothers with positive SARS-CoV-2 test
results were associated with delivery prompted by worsening maternal COVID-19 illness, whereas
the health outcomes of neonates with positive SARS-CoV-2 test results were largely favorable. We
identified minimal neonatal health burden that could be directly associated with SARS-CoV-2
infection within 30 days after hospital discharge.
Previous studies reported a wide range in the percentage of test result positivity among
neonates who were born to mothers with positive SARS-CoV-2 test results. Systematic reviews
reported a 3.1% to 9.1% neonatal test result positivity, but these reviews were prone to publication
bias and included studies that were published before the wide implementation of maternal
surveillance testing, potentially overestimating the true incidence of positive SARS-CoV-2 test results
in neonates.5,6 In contrast, 3 New York City cohorts with larger sample sizes reported virtually no
neonatal test result positivity despite high rates of rooming-in and direct breastfeeding.8,9,18 Given
that 30 newborns in the present cohort were not tested for SARS-CoV-2, it is possible that the
neonatal test result positivity rate is even lower than 2.2%. Overall, the literature suggests low rates
of acquired infection among New York City and Massachusetts neonates who were born to mothers
with positive SARS-CoV-2 test results during the first wave of the pandemic.9,18
The COVID-19 pandemic has disproportionately affected Hispanic and Black communities with
higher infection, morbidity, and mortality rates.26,27 In children, higher SVI, Hispanic ethnicity, and
Black race independently increased the risk of multisystem inflammatory syndrome.28 We found that
high social vulnerability, defined by the maternal zip code, was associated with a nearly 5-fold higher
risk for neonatal test result positivity, although individual-level race/ethnicity and language status
were not associated with a higher risk for neonatal test result positivity. Previous studies have
identified the built environment and other neighborhood variables as factors associated with SARS-
CoV-2 infection in pregnant women29 and adverse perinatal outcomes in general,30,31 but we could
find no published studies that examined the sociodemographic risk factors for test result positivity
among neonates who were exposed to SARS-CoV-2. The association of maternal social vulnerability
with neonatal test result positivity was only slightly attenuated by adjustments for maternal illness
severity, suggesting that nonclinical factors may be at play. We speculate that living in a socially
disadvantaged neighborhood may be a factor in stress-mediated alterations in the maternal and/or
fetal immune response, facilitating SARS-CoV-2 transmission.14,15,32 Given that 4 of 6 neonates with
positive results were born at the same hospital, it is possible that hospital-level factors, such as air
flow or building design, were also at play, although we minimized the impact of hospital-level factors
by accounting for clustering in the multivariate model.
Newborns with positive SARS-CoV-2 test results appeared to have minimal burden of illness
that was directly associated with a viral infection. However, those who were born in the context of
delivery prompted by worsening maternal COVID-19 symptoms were more likely to be preterm
births, which led to a need for resuscitation in the delivery room, CPAP or mechanical ventilation, and
longer length of stay. These results indicate that maternal SARS-CoV-2 infection has an association
with neonatal health, which is brought about not through viral transmission from the mother to the
neonate but rather through the impact of preterm delivery undertaken because of the mother’s
worsening illness.
Few previous studies have ascertained the neonatal outcomes beyond the birth hospitalization.
We leveraged EMR data to identify nonroutine newborn health care visits possibly related to SARS-
CoV-2 infection. Reassuringly, we found very few such encounters. The findings in this study
complement those in the US-based PRIORITY (Pregnancy Coronavirus Outcomes Registry) study,
which involved maternal reporting of newborn outcomes through 6 to 8 weeks of age.17 In the
PRIORITY study, 2 of 80 neonates presented with upper respiratory tract infection symptoms, 0 had
pneumonia, and 0 was rehospitalized; 2 had positive SARS-CoV-2 test results during the follow-up
period.17 In addition, a New York City study with routine clinical follow-up for all neonates exposed to
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SARS-CoV-2 reported no substantial SARS-CoV-2–related illness up to 1 month after hospital
discharge.18 Overall, we did not observe a substantial burden of SARS-CoV-2 among neonates up to 1
month after hospital discharge, although viral testing was limited in this study.
Strengths and Limitations
This study has some strengths. We included 11 academic and community hospitals, representing
more than 50% of all births in Massachusetts, but the findings may not generalize to nonacademic
and level I or II hospitals. Racial and ethnic diversity of the study population was commensurate with
the population in a recent report by the Centers for Disease Control and Prevention of pregnant
women in the US with SARS-CoV-2,33 suggesting generalizability to other US perinatal populations.
We leveraged active hospital-level surveillance for COVID-19 but may have missed a small number
of dyads.
This study has some limitations. Like other studies,34 the present study had limited ability to
differentiate transient colonization from true positive test results in newborns because of a lack of
repeated neonatal testing. In addition, some neonates were not tested during the birth
hospitalization, and few were tested after discharge. Because of our reliance on clinical SARS-CoV-2
testing data, we could not determine the exact timing of maternal infection, especially in mothers
with asymptomatic COVID-19. Although the study sample was large compared with samples in other
published studies, we had limited ability to examine multiple factors simultaneously because only 6
newborns had positive results; residual confounding was possible. Practices evolved during the study
period such that, by month 3, rooming-in and breastfeeding were standard in most, if not all,
hospitals in Massachusetts. Furthermore, the evolution of these practices did not vary by social
factors.23 We were not able to ascertain 30-day outcome data for all neonates because of the
limitations of EMR-based follow-up. Demographic characteristics were similar in mothers and
neonates who had available EMR encounters vs those who did not, but the data on 30-day outcomes
may not be missing at random, preventing firm conclusions.
Conclusions
The neonatal test result positivity rate for SARS-CoV-2 during the birth hospitalization was 2.2% in a
statewide perinatal cohort. Maternal social vulnerability was associated with an increased risk for
neonatal test result positivity, whereas individual-level maternal race/ethnicity and language status
was not. Newborns who had exposure to SARS-CoV-2 were at risk for both direct and indirect
adverse health outcomes, whereas preterm delivery owing to worsening maternal COVID-19 illness
was associated with substantial neonatal morbidity. The findings support ongoing surveillance of the
virus and long-term follow-up.
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